IRIS
RENI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.165
NA - Nord America 1.136
AS - Asia 130
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 7
OC - Oceania 2
Totale 2.447
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.128
SE - Svezia 805
IT - Italia 164
FI - Finlandia 75
CN - Cina 68
IE - Irlanda 40
DE - Germania 38
IN - India 20
GB - Regno Unito 15
HK - Hong Kong 13
IR - Iran 10
FR - Francia 8
EU - Europa 7
NL - Olanda 6
CA - Canada 5
BR - Brasile 4
ES - Italia 4
TR - Turchia 4
CH - Svizzera 3
ID - Indonesia 3
JP - Giappone 3
MX - Messico 3
AT - Austria 2
AU - Australia 2
BD - Bangladesh 2
MM - Myanmar 2
MY - Malesia 2
PE - Perù 2
SG - Singapore 2
AR - Argentina 1
BE - Belgio 1
CZ - Repubblica Ceca 1
IQ - Iraq 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
Totale 2.447
Salva come PNG Salva come JPEG
Città #
Lawrence 342
Princeton 342
Ashburn 106
Helsinki 75
Shanghai 66
New York 61
Milan 50
Dublin 40
Rome 20
Seattle 12
Washington 10
Pune 9
Hong Kong 8
London 8
Hanover 7
Kish 7
Los Angeles 6
Paris 6
Carlsbad 5
Alessandria 4
Brescia 4
Mountain View 4
Mumbai 4
Turin 4
Verona 4
Andover 3
Borås 3
Central 3
Hyderabad 3
Jakarta 3
Treviso 3
Winston-Salem 3
Albizzate 2
Amsterdam 2
Arequipa 2
Berlin 2
Buffalo 2
Castelfranco Emilia 2
Charlotte 2
Chicago 2
Chittagong 2
Cuneo 2
Delhi 2
Düsseldorf 2
Egham 2
Ferrara 2
Gainesville 2
George Town 2
Lecco 2
Madrid 2
Modena 2
Naaldwijk 2
Naples 2
Orem 2
Palermo 2
Providence 2
Puebla City 2
Reggio Emilia 2
Rio de Janeiro 2
Rivoli 2
Rockville 2
San Giuseppe Vesuviano 2
San Maurizio Canavese 2
Santa Clara 2
Settimo Milanese 2
São Paulo 2
Toronto 2
Vienna 2
Aalter 1
Alpharetta 1
Arrecifes 1
Bari 1
Bengaluru 1
Birmingham 1
Boston 1
Boulder 1
Brisbane 1
Campodolcino 1
Columbus 1
Conthey 1
Dundee 1
Eccles 1
Evesham 1
Ferentino 1
Florence 1
Flushing 1
Freiburg 1
Geislingen an der Steige 1
Genoa 1
Gurgaon 1
Hamburg 1
Honolulu 1
Karbala 1
Kowloon 1
Kunming 1
Leawood 1
Lodi 1
Maastricht 1
Marcallo con Casone 1
Messina 1
Totale 1.329
Salva come PNG Salva come JPEG
Nome #
Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment - Risk factors analysis 51
Linee guida AIOM per le neoplasie cerebrali. 35
Evolving pancreatic cancer treatment: From diagnosis to healthcare management 31
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 29
Quaderni dell’infermiere-Neurologia III edizione 26
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen). 25
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients 24
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma 21
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 21
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 19
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma 18
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial 18
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 17
Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC). 17
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 16
XELIRI OR FOLFIRI AS SALVAGE THERAPY IN ADVANCED PANCREATIC CANCER 16
Corneal and Epidermal Nerve Quantification in Chemotherapy Induced Peripheral Neuropathy 16
A multicenter study of treatment of primary CNS lymphoma 15
A MULTICENTER TRIAL ASSESSING FEASIBILITY AND EFFICACY OF A COMBINATION OF HIGH-DOSE METHOTREXATE, CYTARABINE AND THIOTEPA IN PATIENTS WITH PRIMARY CNS LYMPHOMA: IMPACT ON OUTCOME OF CYTARABINE DOSE 15
Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients 15
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma 15
Comment on "prognostic Factors of Survival after Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer": What Is Good for the Surgeon Is Just as Good for the Patient? 15
Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies 15
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 14
A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer 14
A preoperative score to predict early death after pancreatic cancer resection 14
Prediction of early distant recurrence in upfront resectable pancreatic adenocarcinoma: A multidisciplinary, machine learning-based approach 14
Efficacy of endoscopic ultrasound-guided ablation with the hybridtherm probe in locally advanced or borderline resectable pancreatic cancer: A phase ii randomized controlled trial 14
A multicenter study of the prognosis and treatment of adult brain ependymal tumors 14
A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile 13
Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients 13
Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients 13
New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer 13
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study 13
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study 13
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 13
A RANDOMIZED PHASE II TRIAL OF TWO DIFFERENT FOUR DRUG COMBINATIONS IN ADVANCED PANCREATIC ADENOCARCINOMA: CISPLATIN, CAPECITABINE, GEMCITABINE PLUS EITHER EPIRUBICIN OR DOCETAXEL 13
Weekly epirubicin as salvage therapy inpatient with gemcitabine-refractory pancreatic cancer 13
A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients 13
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 12
Justifying vein resection with pancreato-duodenectomy 12
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 12
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial 12
A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia 12
A MULTICENTER RETROSPECTIVE STUDY OF CHEMOTHERAPY IN ADULTS WITH EPENDYMOMA. GICNO (GRUPPO ITALIANO COOPERATIVO NEURO-ONCOLOGIA) 12
3D conformal radiotherapy significantly reduces toxicity of post-prostatectomy adjuvant or salvage irradiation 12
A phase II trial of second-line therapy with trabectedin in metastatic pancreatic adenocarcinoma 12
A randomized phase II trial of adjuvant chemotherapy with cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG regimen) or gemcitabine alone after curative resection for pancreatic cancer 12
Neoadjuvant chemoradiotherapy in patients with esopageal or esophageal gastric junction cancer 12
XELIRI or FOLFIRI as Salvage Therapy in Advanced Pancreatic Cancer 12
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial 12
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 11
The impact of nutritional status on pancreatic cancer therapy 11
Overall Survival With Adjuvant mFOLFIRINOX for Pancreatic Cancer 11
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 11
A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma 11
MATILDE chemotherapy regimen for primary CNS lymphoma Results at a median follow-up of 12 years 11
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial 11
Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-DoseCytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis 11
Pexg (P : Cisplatin, E : Epirubicin, X : Capecitabine, G : Gemcitabine) versus PDXG (D : Docetaxel) regimen in advanced pancreatic cancer: A randomized phase II trial 11
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 11
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants 11
APX005M, a CD40 monoclonal antibody, for patients with pancreatic adenocarcinoma 11
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients 11
A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel 11
A phase II trial of PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced gallbladder, biliary tract, and ampulla of Vater adenocarcinoma, preliminary results 11
Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma 11
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 10
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 10
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 10
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma 10
Diagnostic and therapeutic management of neuroendocrine lung tumors. A clinical study of 44 cases 10
Questions and answers in the management of primary central nervous system and ocular lymphomas 10
Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome 10
Efficacia e sicurezza dei sistemi totalmente impiantabili per accesso vascolare a lungo termine.Studio prospettico 10
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 10
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 10
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 10
Pancreatic cancer: still a cold case? 9
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples 9
Preoperative Chemotherapy Does Not Adversely Affect Pancreatic Structure and Short-Term Outcome after Pancreatectomy 9
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY (CHT) WITH HIGH-DOSE METHOTREXATE (MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (ARAC) FOR PATIENTS (PTS) WITH PRIMARY CNS LYMPHOMA (PCNSL): THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG) #20 TRIAL 9
Solitary clival plasmocytomas: Misleading clinical and radiological features of a rare pathology with a specific biological behaviour. 9
Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas 9
Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer 9
Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study 9
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial 9
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma 9
Post-operative Intensity-Modulated hypofractionated Image-Guided Radiotherapy in cholangiocarcinoma 9
Le infezioni erpetiche nel paziente immunocompromesso 9
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 9
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma 9
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 9
Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion 9
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 8
The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 8
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination 8
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. 8
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 8
Irradiation fields and doses in glioblastoma multiforme: Are current standards adequate? 8
Totale 1.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 2 2 0 13 0 0 10 0 0 1 0 0
2020/202123 0 0 0 1 6 8 7 1 0 0 0 0
2021/2022329 0 0 0 30 10 2 5 232 18 5 8 19
2022/20231.774 786 437 54 14 13 220 50 92 51 17 23 17
2023/2024672 53 52 88 93 84 132 26 86 23 35 0 0
Totale 2.838